ArticleInternal medicine journal2025
Incidence of syphilitic hepatitis among patients with neurosyphilis.
Article in Internal medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Syphilis is a sexually transmitted infection of ongoing public health concern due to its systemic complications, which necessitate early detection and management. As a non-hepatotropic pathogen, syphilis can also cause unexplained hepatitis, a condition that is often overlooked. A retrospective review of 62 patients with neurosyphilis at a metropolitan Australian hospital found that nine (15%) had abnormal liver biochemistry, which improved with antibiotic therapy, consistent with syphilitic hepatitis. This improvement was statistically significant across all liver markers, and the liver pattern of injury was predominantly cholestatic (67%). This study aims to alert clinicians to the incidence and patterns of liver biochemistry abnormalities in syphilis and advise clinicians to perform liver function testing in all patients with neurosyphilis, particularly in high-risk groups. Early detection and diagnosis can prevent unnecessary tests, enable prompt treatment and avoid progression to fulminant hepatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.